Microbiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5879 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Jinwu Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Peking University Third Hospital, Beijing 100191, P.R. China. Hauptthemen laut MEDLINE: PPAR gamma, Indoles, Osteoporosis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Osteoporosis (OP) is increasingly recognised as a disorder driven by impaired lineage allocation of bone marrow stromal cells (BMSCs), characterised by a shift from osteogenesis toward adipogenesis under conditions such as oestrogen deficiency and oxidative stress. Although gut microbiota‑derived metabolites have emerged as critical regulators of skeletal homeostasis, their direct role in BMSC fate determination remains poorly understood. In the present study, indole‑3‑propionic acid (IPA) was identified, a metabolite produced by Clostridium sporogenes, as a key regulator of bone‑fat balance. Integrative analyses combining 16S rRNA sequencing, metabolomics, transcriptomics and functional assays revealed that IPA levels were significantly reduced in ovariectomised mice and positively correlated with bone mass. Functionally, IPA protected BMSCs from oxidative stress‑induced apoptosis, restored osteogenic capacity, and suppressed adipogenic differentiation. Mechanistically, RNA sequencing and molecular docking analyses demonstrated that IPA modulates the peroxisome proliferator‑activated receptor gamma (PPARγ) signalling pathway, thereby reprogramming BMSC lineage commitment. In vivo, oral administration of IPA markedly improved trabecular bone microarchitecture, enhanced bone formation, and corrected marrow adiposity without detectable systemic toxicity. Collectively, the present findings identified IPA as a previously under‑recognised microbiota‑derived metabolite that maintains skeletal homeostasis by restoring the osteogenic‑adipogenic balance through suppression of PPARγ signalling. The present study uncovers a mechanistic link between gut microbial metabolism and BMSC fate regulation and highlights IPA as a promising therapeutic candidate for OP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191, P.R. China.
- Department of Orthopedics, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong 518032, P.R. China.
Zitieren
APA
Bai, J., Wang, R., Fan, J., Su, S., Si, G., You, Q., Sun, A., Hu, D., Gao, S., Lv, Y., & Zhou, F. (2026). Microbiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5879
Vancouver
Bai J, Wang R, Fan J, Su S, Si G, You Q, et al. Microbiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5879
BibTeX
@article{Bai2026,
author = {Bai, Jinwu and Wang, Ruideng and Fan, Jixing and Su, Shilong and Si, Gao and You, Qinyong and Sun, Ao and Hu, Daole and Gao, Shan and Lv, Yang and Zhou, Fang},
title = {Microbiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5879}
}
EUVIMED